Indie Asset Partners, LLC Gilead Sciences, Inc. Transaction History

Indie Asset Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $214,920 - $245,223	-3,582 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $131,031 - $149,304	-2,313 Reduced 39.24%	3,582 $209,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $29,249 - $36,775	471 Added 8.68%	5,895 $373,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $42,752 - $49,644	591 Added 12.23%	5,424 $372,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $3,883 - $4,973	62 Added 1.3%	4,833 $361,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $293,989 - $323,378	4,771 New	4,771 $310,000

1,925

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indie Asset Partners, LLC with notifications on news.